• Home
  • Treatment with palbociclib and an aromatase inhibitor for people with hormone receptor-positive/ human epidermal growth factor receptor 2-negative metastatic breast cancer that has spread to the lungs or liver: a plain language summary.

Treatment with palbociclib and an aromatase inhibitor for people with hormone receptor-positive/ human epidermal growth factor receptor 2-negative metastatic breast cancer that has spread to the lungs or liver: a plain language summary.

Author List
Brufsky A, Liu X, Li B, McRoy L, Chen C, Layman RM, Rugo HS
Publication
Future oncology (London, England)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/613165479
Publication Year
2025
PubMed ID
40159782
Publication Title
Brufsky A, Liu X, Li B, McRoy L, Chen C, Layman RM, Rugo HS. Treatment with palbociclib and an aromatase inhibitor for people with hormone receptor-positive/ human epidermal growth factor receptor 2-negative metastatic breast cancer that has spread to the lungs or liver: a plain language summary. Future Oncol. 2025 May; 21(11):1287-1295.